Skip to main content
    D

    Dyadic International Inc (DYAI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.32
    -0.00 (-1.25%)

    Market Cap: $13.10M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Dyadic International Inc (DYAI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Dyadic International (DYAI) has a market cap of $13.10M and an enterprise value of $14.27M. It kept -254.01% of revenue as net income over the last 12 months. Its share count is up 10.97% from a year earlier.

    Total Valuation

    Enterprise value is 8.95% above the market cap, as debt exceeds cash.

    Market Cap$13.10M
    Enterprise Value$14.27M
    Latest price (Nov 17, 2026)$0.32

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.09% in the quarter ended Sep 30, 2026 and grew 13.92% a year over 2 years.

    Shares Outstanding38.29M
    Shares Change (YoY)+10.97%
    Shares Change (QoQ)+5.09%
    Share Count Growth (2Y CAGR)+13.92%

    Valuation Ratios

    The price to sales ratio is 4.4x. Its year-end P/S ranged from 11.9x to 170.9x from 2016 to 2025.

    P/S Ratio4.4x
    Forward P/S2.0x

    Price Statistics

    The stock is down 65.37% over 52 weeks and trades 21.95% below its 50-day average.

    Beta (1Y)1.02
    52-Week Change-65.37%
    1-Month Change-17.04%
    3-Month Change-57.23%
    6-Month Change-56.17%
    5-Year Change-91.44%
    10-Year Change-76.67%
    Total Return (1Y)-65.37%
    Total Return (3Y CAGR)-43.03%
    Total Return (5Y CAGR)-38.68%
    Max Drawdown (1Y)-78.50%
    Max Drawdown (3Y)-86.08%
    Sharpe Ratio (1Y)-1.25
    Correlation with SPY (1Y)0.17
    50-Day Average$0.41
    200-Day Average$0.73
    52-Week Range$0.30 to $1.60
    RSI (14 Days)34.6
    Average Volume (20 Days)77.02K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.69x current liabilities.

    Current Ratio1.69x
    Quick Ratio1.69x
    Interest Coverage-14.83x

    Returns and Efficiency

    Return on invested capital is -205.53% over the last 12 months.

    Return on Assets (ROA)-88.27%
    Return on Invested Capital (ROIC)-205.53%
    Return on Capital Employed (ROCE)-199.74%
    ROA (5Y Average)-69.52%
    Asset Turnover0.28x
    Receivables Turnover1.94x

    Scores

    DYAI has an Altman Z-Score of -18.65, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-18.65
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $2.76M over the last 12 months is up 4.88% from the 12 months before.

    Revenue$2.76M
    Revenue Growth (YoY)+4.88%
    Gross Profit$486.82K
    Operating Income-$7.30M
    Pretax Income-$7.00M
    Net Income-$7.00M
    EBIT-$6.56M
    Reported EPS (TTM)-$0.20

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$3.93M
    Total Debt$5.10M
    Net Debt$1.17M
    Net Debt Per Share$0.03
    Working Capital$3.22M
    Shareholder Equity-$2.58M
    Total Assets$7.93M
    Total Liabilities$10.51M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $12 of capital spending, operating cash flow left -$7.04M of free cash flow.

    Operating Cash Flow-$7.04M
    Capital Expenditures$12
    Free Cash Flow-$7.04M
    FCF Per Share-$0.18
    Depreciation and Amortization-$5.11K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -264.93%.

    Gross Margin17.66%
    Operating Margin-264.93%
    Pretax Margin-254.01%
    Net Margin-254.01%
    EBIT Margin-237.96%
    FCF Margin-255.20%
    Gross Margin (5Y Average)11.21%

    Growth

    Revenue fell 25.08% a year over 3 years.

    Revenue Growth (3Y CAGR)-25.08%
    Revenue Growth (5Y CAGR)-5.11%
    Book Value Per Share Growth (2Y CAGR)-56.97%
    Tangible Book Per Share Growth (2Y CAGR)-56.97%

    Revenue and profit by year

    Peer Position

    Against 3 similar companies, DYAI has the 3rd highest P/S.

    P/S Ratio4.4x vs 5.3x median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.88% vs -4.60% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 222.80% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+222.80%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DYAI

    What is DYAI's market cap?

    Dyadic International has a market cap of $13.10M. Its enterprise value, which adds debt and subtracts cash, is $14.27M.

    How many shares of DYAI are outstanding?

    Dyadic International has 38.29M shares outstanding. The count is up 10.97% from a year earlier.

    Does DYAI pay a dividend?

    No. Dyadic International does not pay a dividend.

    How much debt does DYAI have?

    Dyadic International has $5.10M of total debt and $3.93M of cash and equivalents, a net debt position of $1.17M.